Telomere length as a systemic aging-related susceptibility marker for trigeminal neuralgia: Genetic evidence from mendelian randomization.
Shorter cellular aging markers appear linked to trigeminal neuralgia risk, opening new avenues for understanding this severe pain condition.
ObjectiveTo evaluate whether genetically proxied leukocyte telomere length (TL), a systemic marker of biological aging and cumulative cellular stress, is associated with trigeminal neuralgia (TN) risk,BackgroundTN is a severe craniofacial pain disorder classically attributed to neurovascular compression and focal trigeminal root demyelination. These findings identify leukocyte telomere length as a candidate systemic aging-related susceptibility marker for trigeminal neuralgia and support further studies integrating telomere biology with neurovascular compression grading, trigeminal nerve morphometry, and clinical outcomes.
What the study was
- Study design
- Mendelian randomization study
- Category
- Genomics/Precision Medicine
- Maturity
- Validated
- Journal
- Molecular pain
Why it surfaced
Abstract-reviewed mendelian randomization study scored conservatively for genomics/precision medicine; 7/10 reflects the available design, relevance, novelty, and population or unmet-need evidence.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.